Lantheus Announces Acquisition Of Cerveau Technologies, Inc., Expanding Imaging Pipeline Into Alzheimer’S Disease
Acquiring Company
Lantheus Holdings
Acquired Company
Cerveau
Description
Lantheus Holdings, Inc. (“Lantheus”) (NASDAQ: LNTH), a company committed to improving patient outcomes through diagnostics, radiotherapeutics and artificial intelligence solutions that enable clinicians to Find, Fight and Follow disease, today announced it has acquired Knoxville-based Cerveau Technologies, Inc. (“Cerveau”). Cerveau’s asset is MK-6240, a second-generation F 18-labeled positron emission tomography (“PET”) imaging agent that targets Tau tangles in Alzheimer’s disease.
Quick answer
Lantheus Holdings is acquiring Cerveau, announced February 6, 2023. Lantheus Holdings is based in Bedford, Massachusetts, United States.
- How much did Lantheus Holdings pay for Cerveau?
- The deal value was not disclosed.
- What does Lantheus Holdings do?
- Lantheus is the leading radiopharmaceutical-focused company, delivering life-changing science to enable clinicians to Find, Fight and Follow disease to deliver better patient outcomes.
- Where are Lantheus Holdings and Cerveau based?
- Lantheus Holdings is based in Bedford, Massachusetts, United States.
- Who are the decision-makers at Lantheus Holdings?
- Fundz holds 1 contact at Lantheus Holdings. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Other recent acquisitions in Therapeutics and Biotechnology
Deals where the buyer or target shares a sector with this one, within 45 days, from Fundz verified event records.
- Sumitovant Biopharma Completes Acquisition Of Myovant Sciences (March 10, 2023)
- Rhythm Pharmaceuticals Announces Acquisition Of Xinvento B.V. And Portfolio Of Investigational Therapeutics (February 27, 2023)
- Kymanox Acquires Eu Based Anteris Medical And Anteris Helvetia (February 2, 2023)
- Shockwave Medical To Acquire Neovasc (January 17, 2023)
- Shockwave Medical Announces Agreement To Acquire Neovasc (January 17, 2023)
- Merck Completes Tender Offer To Acquire Imago Biosciences, Inc. (January 11, 2023)
Who to call at Lantheus Holdings, and when
When Lantheus Holdings changes hands, the new owners review vendors, systems and leadership. That is when the door opens.
- An alert the day Lantheus Holdings raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Lantheus Holdings, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Lantheus Holdings. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Lantheus Holdings makes an acquisition, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Frequently asked
Who acquired Cerveau?
Cerveau was acquired by Lantheus Holdings, based in Bedford. The deal was reported on February 6, 2023. Lantheus is the leading radiopharmaceutical-focused company, delivering life-changing science to enable clinicians to Find, Fight and Follow disease to deliver better patient outcomes. Lantheus Holdings is publicly traded (LNTH) and operates in Biotechnology.
When did Lantheus Holdings acquire Cerveau?
Lantheus Holdings's acquisition of Cerveau was reported on February 6, 2023. Lantheus Holdings, Inc. Fundz records the date the transaction was first publicly reported, sourced from filings and company announcements.
What does Cerveau do?
Cerveau’s vision is to be the premier provider of information and technology to researchers and clinicians in order to improve brain health. For more information, visit www.cerveautechnologies.com. It is privately held, operating in Information Technology.
This company was part of an acquisition. Fundz tracks who bought whom, and who to call on both sides.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.